
TZS 70,000
In stock
AND CHILDREN. IT HELPS CONTROL FOCAL-ONSET SEIZURES AND CERTAIN GENERALIZED SEIZURE TYPES, INCLUDING MYOCLONIC AND PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN APPROPRIATE PATIENTS. IT WORKS BY BINDING TO SYNAPTIC VESICLE PROTEIN SV2A, HELPING REGULATE NEUROTRANSMITTER RELEASE AND REDUCE ABNORMAL ELECTRICAL ACTIVITY IN THE BRAIN. THE ORAL SOLUTION PROVIDES FLEXIBLE DOSING AND IS PARTICULARLY USEFUL FOR PATIENTS WHO HAVE DIFFICULTY SWALLOWING TABLETS.